封面
市場調查報告書
商品編碼
2045913

醫療設備外包市場-全球產業規模、佔有率、趨勢、機會、預測:按服務、應用、類別、地區和競爭格局分類,2021-2031年

Medical Device Outsourcing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service, By Application, By Class, By Region & Competition, 2021-2031F

出版日期: | 出版商: TechSci Research | 英文 189 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球醫療設備外包市場預計將從 2025 年的 1,320.2 億美元大幅成長至 2031 年的 2,764.7 億美元,複合年成長率為 13.11%。

這一成長主要源於目的地設備製造商 (OEM) 擴大將產品設計、原型製作、生產製造和法規遵循等關鍵任務外包給第三方供應商。推動這項轉變的關鍵因素包括:提高成本效益的迫切需求、加快新產品上市速度的願望,以及使企業能夠集中內部專業知識於研發和行銷等核心職能的策略重點。

市場概覽
預測期 2027-2031
市場規模:2025年 1320.2億美元
市場規模:2031年 2764.7億美元
複合年成長率:2026-2031年 13.11%
成長最快的細分市場 循環系統
最大的市場 北美洲

醫療技術產業的結構構成進一步加劇了其對外部支援的依賴。例如,根據歐洲醫療技術協會(MedTech Europe)的報告,到2025年,中小企業(SME)將佔歐洲醫療技術產業的約90%。這些小規模的公司往往缺乏實現完全垂直整合所需的資金和基礎設施,因此與專業的契約製造組織(CMO)合作對於彌合能力差距、取得商業性成功至關重要。

市場促進因素

對成本控制和提升營運效率日益成長的需求是主要驅動力,迫使目的地設備製造商 (OEM) 重組資產並與外部合作夥伴合作。醫療保健政策帶來的降價壓力以及通貨膨脹對生產成本的影響,正促使企業從固定成本的內部生產模式轉向更靈活、可變成本的外包模式,以保障利潤率。這種生產規模的策略性轉變使企業能夠在降低營運成本的同時,保持供應鏈的靈活性。 Integer Holdings Corporation 2024 年第三季 9% 的銷售額成長便印證了這一點,這主要得益於對專業製造的持續需求。

此外,隨著醫療設備設計日益複雜,往往需要高度專業化的技術專長,與擁有超越內部OEM廠商能力範圍的利基技能的供應商建立合作關係變得愈發重要。現代醫療技術擴大融合了精密的電子元件和演算法,由此產生的知識缺口難以被傳統的內部工程團隊彌補。因此,OEM廠商不得不依賴在數位健康整合方面擁有專業知識的外部合作夥伴,以確保功能準確性。 FDA在2024年8月前核准了950款人工智慧/機器學習(AI/ML)醫療設備,這一事實凸顯了對專業開發支援日益成長的需求,也印證了這一趨勢。此類創新仰賴領先開發公司的雄厚資金,正是這些公司的財務基礎支撐著這些複雜的外部夥伴關係。

市場挑戰

日益嚴格的監管是醫療設備外包市場成長的一大結構性障礙。政府機構強制執行嚴格的品管標準,增加了在分散的供應鏈中維持合規性的複雜性。這種監管負擔往往會抵消速度和柔軟性帶來的優勢,迫使製造商投入大量時間審查第三方合作夥伴。因此,管理外部供應商固有的行政摩擦導致企業在擴大外包範圍方面猶豫不決,在某些情況下,甚至為了確保全面監管而將關鍵職能保留在內部。

此外,這種嚴苛的監管環境所帶來的財務影響是市場擴張的主要障礙。醫療設備認證和綜合文件成本的不斷上漲,使得原本可用於外包合約的預算捉襟見肘。責任風險也在增加,因此需要簽訂更嚴格的合作協議。 MedTech Europe 2025年的調查報告也印證了這種財務壓力。報告發現,與先前的指令相比,新法規下的認證和維護成本增加了高達100%,導致可用於外包服務的資金減少,並減緩了整體市場成長。

市場趨勢

關鍵的新趨勢包括供應鏈韌性和近岸外包策略的採用。這是因為製造商正努力保護其業務免受全球不穩定因素的影響。為了直接應對日益緊張的地緣政治局勢和物流瓶頸,目的地設備製造商 (OEM) 正在積極拓展供應商網路,並實施預測性風險監控工具,以確保病患照護的持續性。這種防禦性重組優先考慮零件供應,而非僅僅追求最低價格,這標誌著營運模式從效率驅動型轉變為韌性驅動型的根本性。 Resilinc 在 2024 年第一季報告稱,醫療保健供應鏈中斷警報數量同比成長 40%,進一步凸顯了這一需求。

同時,在對先進電子設備日益成長的需求以及物聯網 (IoMT) 在醫療保健領域的整合推動下,互聯穿戴式醫療設備的開發外包顯著增加。由於這些設備需要複雜的組裝和先進的工程技術,而這些是企業內部無法完成的,因此原始設備製造商 (OEM) 擴大將大規模合約外包給專業的電子製造服務供應商。這種對外部專業知識的依賴使醫療保健公司能夠快速擴大數位健康解決方案的生產規模,同時有效應對與現代連接相關的技術複雜性。對這種高科技製造夥伴關係關係的需求正在加速成長,Plexus 公司於 2024 年 7 月宣布的新製造計劃證明了這一點,該訂單達到了 2.79 億美元,其中大部分來自醫療保健和生命科學領域。

目錄

第1章概述

第2章:調查方法

第3章執行摘要

第4章:客戶心聲

第5章:全球醫療設備外包市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 服務類別(品質保證、法規遵循服務、產品設計與開發服務、產品測試與滅菌服務、產品實施服務、產品升級服務、產品維護服務、契約製造)
    • 依應用領域(心臟病學、診斷影像、整形外科、體外診斷 (IVD)、眼科、一般外科和整形外科、藥物傳輸、牙科、內視鏡檢查、糖尿病護理、其他)
    • 按類別(I類、II類、III類)
    • 按地區
    • 按公司(2025 年)
  • 市場地圖

第6章:北美醫療設備外包市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲:國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章:歐洲醫療設備外包市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲:國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章:亞太地區醫療設備外包市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區:國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章:中東和非洲醫療設備外包市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲:國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章:南美醫療設備外包市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲:國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章:全球醫療設備外包市場:SWOT分析

第14章:波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Laboratory Corporation of America Holdings
  • Pace Analytical Services, Inc.
  • Intertek Group plc
  • PAREXEL International Corporation
  • Accell Clinical Research, LLC
  • Criterium, Inc.
  • ICON plc.
  • IQVIA Inc.
  • Integer Holdings Corporation

第16章 策略建議

第17章:關於研究公司及免責聲明

簡介目錄
Product Code: 28343

The global medical device outsourcing market is projected to expand significantly, from USD 132.02 billion in 2025 to USD 276.47 billion by 2031, demonstrating a compound annual growth rate of 13.11%. This growth is driven by Original Equipment Manufacturers (OEMs) increasingly engaging third-party providers for critical functions like product design, prototyping, manufacturing, and regulatory adherence. Key factors motivating this shift include the urgent need for cost efficiencies, the desire to expedite market entry for new products, and a strategic focus allowing companies to allocate internal expertise to core activities such as research and marketing.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 132.02 Billion
Market Size 2031USD 276.47 Billion
CAGR 2026-203113.11%
Fastest Growing SegmentCardiology
Largest MarketNorth America

The structural makeup of the medical technology industry further reinforces this dependence on external support. For instance, in 2025, small and medium enterprises (SMEs) constituted roughly 90% of Europe's medical technology sector, as reported by MedTech Europe. These smaller firms frequently lack the necessary capital and infrastructure for complete vertical integration, making collaboration with specialized contract manufacturing organizations essential to fill capability gaps and achieve commercial success.

Market Driver

The increasing demand for cost control and improved operational efficiency is a primary driver, pushing original equipment manufacturers (OEMs) to reorganize their assets and engage external partners. With healthcare systems pressing for reduced prices and inflation affecting production costs, companies are moving from fixed-cost internal manufacturing to more flexible, variable-cost outsourcing models to protect their profit margins. This strategic shift in production volume enables firms to lower overheads while ensuring the agility of their supply chains, as evidenced by Integer Holdings Corporation's 9% sales increase in Q3 2024, attributed to sustained demand for specialized manufacturing.

Furthermore, the growing intricacy of device design, which often requires highly specialized technical expertise, increasingly necessitates partnerships with providers possessing niche skills beyond internal OEM capabilities. Modern medical technologies are increasingly incorporating advanced electronics and algorithms, leading to a knowledge gap that traditional internal engineering teams struggle to fill alone. This compels OEMs to rely on external partners proficient in digital health integration to ensure functional precision, a trend highlighted by the FDA's authorization of 950 AI/ML-enabled medical devices by August 2024, underscoring the demand for expert development support. Such innovation relies on the substantial capital of leading developers, whose financial foundation enables these intricate external partnerships.

Market Challenge

The increasingly stringent regulatory landscape represents a significant structural impediment to the growth of the medical device outsourcing market. Government bodies' enforcement of rigorous quality management standards intensifies the complexity of maintaining compliance across fragmented supply chains. This regulatory burden often offsets the benefits of speed and flexibility, requiring manufacturers to commit substantial time to auditing third-party partners. Consequently, the administrative friction inherent in managing external vendors discourages companies from expanding their outsourcing portfolios, sometimes prompting them to retain critical operations internally for absolute oversight.

Furthermore, the financial implications of this stringent environment create a considerable barrier to market expansion. The elevated costs of certifying devices and maintaining comprehensive documentation strain budgets that would otherwise fund external contracts. Liability risks also escalate, necessitating more restrictive partnership agreements. This financial pressure is evident in findings by MedTech Europe from 2025, which indicated that certification and maintenance costs under new regulations had increased by up to 100 percent compared to prior directives, thereby reducing the capital available for outsourcing services and dampening overall market growth.

Market Trends

A critical emerging trend is the adoption of supply chain resilience and nearshoring strategies, as manufacturers aim to safeguard their operations from global instability. In direct response to escalating geopolitical tensions and logistical bottlenecks, Original Equipment Manufacturers (OEMs) are actively diversifying their supplier networks and implementing predictive risk monitoring tools to guarantee uninterrupted patient care. This defensive restructuring prioritizes securing component availability over merely achieving the lowest price, signaling a fundamental shift from efficiency-focused to resilience-focused operational models, a need underscored by the 40% year-over-year increase in healthcare supply chain disruption alerts reported by Resilinc in Q1 2024.

Simultaneously, there is a notable upward trend in outsourcing the development of connected and wearable medical devices, spurred by the growing demand for sophisticated electronics and the integration of the Internet of Medical Things (IoMT). Given that these devices necessitate complex assembly and advanced engineering capabilities often beyond internal capacities, OEMs are increasingly awarding substantial contracts to specialized electronic manufacturing services providers. This reliance on external expertise enables medical companies to rapidly scale the production of digital health solutions while effectively managing the technical complexities associated with modern connectivity. The demand for such high-tech manufacturing partnerships is accelerating, as evidenced by Plexus Corp's July 2024 report of $279 million in new manufacturing program wins, significantly driven by the Healthcare and Life Sciences sector.

Key Market Players

  • Laboratory Corporation of America Holdings
  • Pace Analytical Services, Inc.
  • Intertek Group plc
  • PAREXEL International Corporation
  • Accell Clinical Research, LLC
  • Criterium, Inc.
  • ICON plc.
  • IQVIA Inc.
  • Integer Holdings Corporation

Report Scope

In this report, the Global Medical Device Outsourcing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Medical Device Outsourcing Market, By Service

  • Quality Assurance
  • Regulatory Affairs Services
  • Product Design and Development Services
  • Product Testing & Sterilization Services
  • Product Implementation Services
  • Product Upgrade Services
  • Product Maintenance Services
  • Contract Manufacturing

Medical Device Outsourcing Market, By Application

  • Cardiology
  • Diagnostic Imaging
  • Orthopedic
  • IVD
  • Ophthalmic
  • General and Plastic Surgery
  • Drug Delivery
  • Dental
  • Endoscopy
  • Diabetes Care
  • Others

Medical Device Outsourcing Market, By Class

  • Class I
  • Class II
  • Class III

Medical Device Outsourcing Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Medical Device Outsourcing Market.

Available Customizations:

Global Medical Device Outsourcing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Medical Device Outsourcing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Service (Quality Assurance, Regulatory Affairs Services, Product Design and Development Services, Product Testing & Sterilization Services, Product Implementation Services, Product Upgrade Services, Product Maintenance Services, Contract Manufacturing)
    • 5.2.2. By Application (Cardiology, Diagnostic Imaging, Orthopedic, IVD, Ophthalmic, General and Plastic Surgery, Drug Delivery, Dental, Endoscopy, Diabetes Care, Others)
    • 5.2.3. By Class (Class I, Class II, Class III)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Medical Device Outsourcing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Service
    • 6.2.2. By Application
    • 6.2.3. By Class
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Medical Device Outsourcing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Service
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By Class
    • 6.3.2. Canada Medical Device Outsourcing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Service
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By Class
    • 6.3.3. Mexico Medical Device Outsourcing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Service
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By Class

7. Europe Medical Device Outsourcing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Service
    • 7.2.2. By Application
    • 7.2.3. By Class
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Medical Device Outsourcing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Service
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Class
    • 7.3.2. France Medical Device Outsourcing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Service
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Class
    • 7.3.3. United Kingdom Medical Device Outsourcing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Service
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Class
    • 7.3.4. Italy Medical Device Outsourcing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Service
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By Class
    • 7.3.5. Spain Medical Device Outsourcing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Service
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By Class

8. Asia Pacific Medical Device Outsourcing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Service
    • 8.2.2. By Application
    • 8.2.3. By Class
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Medical Device Outsourcing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Service
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Class
    • 8.3.2. India Medical Device Outsourcing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Service
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Class
    • 8.3.3. Japan Medical Device Outsourcing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Service
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Class
    • 8.3.4. South Korea Medical Device Outsourcing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Service
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By Class
    • 8.3.5. Australia Medical Device Outsourcing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Service
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By Class

9. Middle East & Africa Medical Device Outsourcing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Service
    • 9.2.2. By Application
    • 9.2.3. By Class
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Medical Device Outsourcing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Service
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Class
    • 9.3.2. UAE Medical Device Outsourcing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Service
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Class
    • 9.3.3. South Africa Medical Device Outsourcing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Service
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Class

10. South America Medical Device Outsourcing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Service
    • 10.2.2. By Application
    • 10.2.3. By Class
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Medical Device Outsourcing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Service
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Class
    • 10.3.2. Colombia Medical Device Outsourcing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Service
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Class
    • 10.3.3. Argentina Medical Device Outsourcing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Service
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Class

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Medical Device Outsourcing Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Laboratory Corporation of America Holdings
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Pace Analytical Services, Inc.
  • 15.3. Intertek Group plc
  • 15.4. PAREXEL International Corporation
  • 15.5. Accell Clinical Research, LLC
  • 15.6. Criterium, Inc.
  • 15.7. ICON plc.
  • 15.8. IQVIA Inc.
  • 15.9. Integer Holdings Corporation

16. Strategic Recommendations

17. About Us & Disclaimer